HIMCH
TVTX icon

Hartford Investment Management Co (HIMCO)’s Travere Therapeutics TVTX Stock Holding History

Hartford Investment Management Co (HIMCO)’s Portfolio TVTX Stock Details TVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-7,442
Closed -$214K – 783
2018
Q3 		$214K Sell
7,442
-496
-6% -$14.2K 0.01% 736
2018
Q2 		$216K Buy
+7,938
New +$211K 0.01% 748

Other funds holding TVTX

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Hartford Investment Management Co (HIMCO)'s TVTX Position: Q4 2018 in Review

Hartford Investment Management Co (HIMCO) sold out of Travere Therapeutics (TVTX) in Q4 2018, closing a stake of 7,442 shares — an estimated $214K sold.

Hartford Investment Management Co (HIMCO) first reported a position in TVTX in Q2 2018 and held it in 2 quarters. The position peaked at $216K in Q2 2018. 130 funds tracked by Wall St. Rank hold TVTX as of Q4 2018.

  • Hartford Investment Management Co (HIMCO) reported no remaining Travere Therapeutics position as of Q4 2018 after selling out during the quarter.
  • Hartford Investment Management Co (HIMCO) sold 7,442 Travere Therapeutics shares in Q4 2018, an estimated $214K.
  • Hartford Investment Management Co (HIMCO) first reported a position in Travere Therapeutics in Q2 2018 and held it in 2 quarters.
  • Hartford Investment Management Co (HIMCO)'s Travere Therapeutics position peaked at $216K in Q2 2018.
  • 130 funds tracked by Wall St. Rank held Travere Therapeutics as of Q4 2018.

Based on Hartford Investment Management Co (HIMCO)'s 13F filing for Q4 2018, filed 4 Feb 2019.